Why This Pharmaceutical Stock Jumped Close to 100% This Week
It is getting acquired by a larger firm in the sector.
Read the full articleYou might also wanna read

Pharma stocks are showing strength. Charts predict this name could break out next
Pharmaceutical stocks have recently separated themselves from the broader market, and the group has become a source of leadership within hea
Recent moves of note in and around the biotech and pharma industries
Recent moves of note in and around the biotech and pharma industries
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
Deal would rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
Eli Lilly’s $400 Billion Surge Is Reshaping Big Pharma
Roughly $400 billion. That is how much market value Eli Lilly (NYSE:LLY) has added over the past year, with shares climbing from $773.86 on
Why Crinetics Stock Soared 99% This Week
Crinetics Pharmaceuticals (NASDAQ:CRNX) shares have climbed 99% just this week, from $42.03 at Monday’s close, to $83.54 earlier today. The

This medtech stock is trading at a discount to peers. BTIG says it's a buy
Medtronic's shares are cheap relative to those of its competitors, making now a good time to add the stock to one's portfolio, per BTIG.

Comments
Sign in to join the conversation.
No comments yet. Be the first.